Three spinocerebellar ataxia type 2 siblings with ataxia, parkinsonism, and motor neuronopathy

Internal Medicine

Volumn 50, Issue 13, 2011, Pages 1429-1432

  Nishikawa, Noriko ^a   Nagai, Masahiro ^a   Tsujii, Tomoaki ^a   Tanabe, Nachi ^a   Takashima, Hiroshi ^b   Nomoto, Masahiro ^a  

^a EHIME UNIVERSITY HOSPITAL   (Japan)

^b KAGOSHIMA UNIVERSITY   (Japan)

Author keywords

Ataxia; Motor neuron disease; Neurodegenerative disorders; Parkinsonism; Sca2

Indexed keywords

CARBIDOPA PLUS LEVODOPA; LEVODOPA;

ADULT; ALLELE; ARTICLE; ATAXIA; AUTOSOMAL DOMINANT INHERITANCE; BRADYKINESIA; BRAIN ATROPHY; CAG REPEAT; CASE REPORT; DISEASE COURSE; DYSKINESIA; FEMALE; GENETIC ANALYSIS; HUMAN; MALE; MOTOR NEUROPATHY; MUSCLE ATROPHY; MUSCLE RIGIDITY; MUSCLE WEAKNESS; NUCLEAR MAGNETIC RESONANCE IMAGING; PARKINSONISM; SPINOCEREBELLAR ATAXIA TYPE 2; SPINOCEREBELLAR DEGENERATION; TREMOR;

ATAXIA; FEMALE; HUMANS; MALE; MIDDLE AGED; MOTOR NEURON DISEASE; NERVE TISSUE PROTEINS; PARKINSONIAN DISORDERS; PEDIGREE; SIBLINGS; SPINOCEREBELLAR ATAXIAS;

EID: 79960040674     PISSN: 09182918     EISSN: 13497235     Source Type: Journal    
DOI: 10.2169/internalmedicine.50.5262     Document Type: Article

References (15)

1. Gispert S, Twells R, Orozco G, et al. Chromosomal assignment of the second locus for autosomal dominant cerebellar ataxia (SCA2) to chromosome 12q23-24.1. Nat Genet 4: 295-299, 1993.
2. Pulst SM, Nechiporuk A, Nechiporuk T, et al. Moderate expansion of a normally biallelic trinucleotide repeat in spinocerebellar ataxia type 2. Nat Genet 14: 269-276, 1996.
3. Furtado S, Farrer M, Tsuboi Y, et al. SCA-2 presenting as parkin-sonism in an Alberta family: clinical, genetic, and PET findings. Neurology 59: 1625-1627, 2002.
4. Lu CS, Wu Chou YH, Yen TC, Tsai CH, Chen RS, Chang HC. Dopa-responsive parkinsonism of spinocerebellar ataxia type 2. Mov Disord 17: 1046-1051, 2002.
5. Pulst SM, Nechiporuk A, Nechiporuk T, et al. Moderate expansion of a normally biallelic trinucleotide repeat in spinocerebellar ataxia type 2. Nat Genet 14: 269-276, 1996.
6. 123I-metaiodobenzylguanidine myocardial scintigraphy in Parkinson's disease. J Neurol Neurosurg Psychiatry 67: 189-194, 1999.
7. Infante J, Berciano J, Volpini V, et al. Spinocerebellar ataxia type 2 with levodopa-responsive parkinsonism culminating in motor neuron disease. Mov Disord 19: 848-852, 2004.
8. Sasaki H, Fukazawa T, Wakisaka A, et al. Central phenotype and related varieties of spinocerebellar atxia type 2 (SCA2): a clinical and genetic study with a pedigree in the Japanese. J Neurol Sci 144: 176-181, 1996.
9. Estrada R, Galarraga J, Orozco G, Nodarse A, Auburger G. Spi-nocerebellar ataxia type 2 (SCA2): morphometric analyses in 11 autopsies. Acta Neuopathol 97: 306-310, 1999.
10. Kim JM, Hong S, Kim GP, et al. Importance of low-range CAG expansion and CAA interruption in SCA2 Parkinsonism. Arch Neurol 64: 1510-1518, 2007.
11. Charles P, Camuzat A, Benammar N, et al. Are interrupted SCA2 CAG repeat expansions responsible for parkinsonism? Neurology 69: 1970-1975, 2007.
12. Momeni P, Lu CS, Chou YW, et al. Taiwanese cases of SCA2 are derived from a single founder. Mov Disord 20: 1633-1636, 2005.
13. Sasaki H, Wakisaka A, Sanpei K, et al. Phenotype variation correlates with CAG repeat length in SCA2: a study of 28 Japanese patients. J Neurol Sci 159: 202-208, 1998.
14. Matsuura T, Sasaki H, Yabe I, et al. Mosaicism of unstable CAG repeats in the brain of spinocerebellar ataxia type 2. J Neurol 246: 835-839, 1999.
15. Elden AC, Kim HJ, Hart MP, et al. Ataxin-2 intermediate-length polyglutamine expansions are associated with increased risk for ALS. Nature 466: 1069-1075, 2010.